Magnevist

Active Ingredient(s): Gadopentetate
First Approved by the FDA: June 2, 1988
Pharmaceutical Company: BERLEX

Welcome to the Magnevist information hub.
Scroll down to read supplemental details and discuss this drug.

Magnevist Overview

Gadopentetic acid is one of the trade names for a gadolinium -based MRI contrast agent, usually administered as a salt of a complex of gadolinium with DTPA (diethylenetriaminepentacetate ) with the chemical formula A2[Gd(DTPA)(H2O)]; when cation A is the protonated form of the amino sugar meglumine the salt goes under the name "Gadopentetate dimeglumine". It was described in 1981 and introduced as the first MRI contrast agent in 1987. It is used to assist imaging of blood vessels and of inflamed ...

Read more Magnevist Details
Details May Include Instructions, Side Effects, Interactions, Etc.
Drug monograph is from Wikipedia. All text is available under the terms of the GFDL
(GNU Free Documentation License) | http://en.wikipedia.org/wiki/Gadopentetic_acid

Recent Magnevist Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Gadopentetate

Injection: 469.01mg/ml, 496.01mg/ml
Solution: 529mg/ml

Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Gadopentetate or a similar ingredient: (1 result)

Gadopentetate